HOME >> MEDICINE >> NEWS
Mount Sinai Researchers present findings on treatments for prostate and breast cancer

Researchers from the Department of Radiation Oncology and the Milton and Caroll Petrie Department of Urology at Mount Sinai School of Medicine are presenting findings from ten studies of prostate and breast cancer treatments at the 47th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), October 16-20, 2005, in Denver, Colorado.

The research results being detailed:

  • A higher incidence of ATM gene variants in African American Women. (Lead author: G. Fan)
  • A significant percentage (at seven years minimum) of men with normal pre-treatment sexual function were able to experience a high rate of erectile function as quantified by the IIEF-5 and physician assigned a scoring system. (Lead author: J.A. Cesaretti)
  • Possession of a mutated ATM gene is associated with the development of grade 2 proctitis for patients treated with 125I brachytherapy. (Lead author: J.A. Cesaretti)
  • A specific genetic alteration is predictive for the development of late adverse radiotherapy responses among breast cancer patients treated with adjuvant radiation therapy. (Lead author: A.Y. Ho)
  • Prostate brachytherapy is generally well tolerated and appears to be safe in patients with a history of IBD. (Lead author: C.A. Peters)
  • If biologically effective doses can be achieved, excellent long-term biochemical and local control rates can be realized. (Lead author: R.G. Stock)
  • Overall long term morbidity associated with brachytherapy with or without HT and EBRT is low. (Lead author: N.N. Stone)
  • Insight into patient's erectile function post-brachytherapy can b well-assessed using the Mount Sinai Erectile Function Scale, along with, the International Index of Erectile Function-15. (Lead author: T.M. Zagar)
  • Ultrasound-guided brachytherapy is a reasonable salvage option for patients with biopsy proven biochemical recurrence following definitive external beam radiation therapy. (Lead author:
    '"/>


Contact: Mount Sinai Press Office
newsmedia@mssm.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
18-Oct-2005


Page: 1 2

Related medicine news :

1. New breakthrough treatment for spinal cancer patients at Mount Sinai
2. Mount Sinai and EXACT Sciences announce study results on study stool DNA testing for colon cancer
3. Wiley to assume publication of Mount Sinai Journal of Medicine
4. Mount Sinai researcher finds drinking water safe to drink
5. The Mount Sinai Medical Center recognized for excellence in bariatric surgery
6. Mount Sinai Global Health Center receives $1M grant
7. Mount Sinai School of Medicine receives prestigious AAMC Grant for Chronic Illness Care education
8. Mount Sinai and YAI/NIPD Network join forces to further quality of care for people with autism
9. Mount Sinai launches combination therapy trial to treat Relapsing-Remitting Multiple Sclerosis
10. CNIC commits 5 million Euros to the Mount Sinai School of Medicine
11. Mount Sinai expands cutting-edge molecular testing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate Institute’s Alumni ... line-up of events for its annual meeting “Coming Home 2017,” an activity-packed weekend ... Home 2017” will be held on Friday January 27 through Sunday, January 29, ...
(Date:1/21/2017)... ... 2017 , ... The Nobel Biocare™ dental implant company is ... its creos™ line of bone regenerative products. Specifically, the Nobel Biocare™ ... creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In addition ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin ... pure essential oils, announced the company had a successful visit to the 2017 ECRM ... event gives companies that work in the nutritional, sports and health industries a chance ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based company ... attended the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding ... range of supplements that keep the body functioning at its peak performance by ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has launched two ... drinks have been produced in collaboration with Zlatan Ibrahimovic and have been developed ... After a successful launch in Sweden last year, the next generation sports drinks ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... 2017  Palladian Health, a leading provider of ... of an opioid management program which assists physicians ... helps stem the growing tide of dependence on ... chronic non-cancer pain (back pain, neck pain, and ... of evidence regarding long-term effectiveness. The ...
(Date:1/20/2017)... January 20, 2017 Avillion LLP, a co-developer ... Mark Weinberg , MD MBA as Chief Medical Officer. Dr ... USA . ... Dr Weinberg has spent more than 17 years as a ... companies to micro-cap biotech. Over the course of his career, he ...
(Date:1/19/2017)... -- Report Details What can be expected ... to grow at the fastest rates? This visiongain report ... opportunities and prospects. Our 190-page report provides 124 ... in the industry and the future market prospects. Our ... all the major categories of the ophthalmic devices market. ...
Breaking Medicine Technology:
Cached News: